Results 51 to 60 of about 7,279 (128)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma

Journal of Immunology Research, 2017
Nampt including eNampt and iNampt may contribute to mediating obesity-associated cancers. This study investigated the role of Nampt in esophagogastric junction adenocarcinoma (EGA), a cancer strongly correlated with obesity.
Haijun Li, E. Bai, Yong Zhang, Zhuoqi Jia, Shicai He, Junke Fu   +5 more
doaj   +1 more source

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction

Endoscopy International Open, 2014
Background and Study Aims There are a few reports about the efficacy of endoscopic submucosal dissection (ESD) for adenocarcinomas of the esophagogastric junction (EGJ).
Yasuaki Nagami, Hirohisa Machida, Masatsugu Shiba, Tomoko Obayashi, Masaki Ominami, Shusei Fukunaga, Satoshi Sugimori, Hirokazu Yamagami, Tetsuya Tanigawa, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga, Yasuhiro Fujiwara, Tetsuo Arakawa   +13 more
doaj   +1 more source

Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Gastric cancer and gastroesophageal junction cancer, primarily adenocarcinoma, originate in the stomach's mucosa. Peritoneal metastasis is a common pattern in gastric cancer. The neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR), as systemic inflammation indicators, change before clinical symptoms, aiding early ...
Mahesh Wadhwa, Dipali Raju, Harish Premkumar, Nawaz Usman, Preethi S. Shetty, Naveena A. N. Kumar   +5 more
wiley   +1 more source

Expression of Programmed Cell Death 1 and Lymphocyte Activation Gene 3 in Perioperation of Adenocarcinoma of Esophagogastric Junction and Related Significance

Zhongliu Fangzhi Yanjiu, 2019
Objective To evaluate the expression of programmed cell death 1 (PD-1) and lymphocyte activation gene 3 (LAG-3) in lymphocytes following surgery for advanced adenocarcinoma of esophagogastric junction(AEGJ), and to understand the effect of radical ...
ZHANG Wei, LI Shoumiao, GONG Yanxin, LI Baozhong, ZHANG Zhizhong, LIU Zhiqiang   +5 more
doaj   +1 more source

MET‐amplified gastric cancers exhibit co‐amplifications of BRAF, CDK6, and EGFR

The Journal of Pathology: Clinical Research, Volume 12, Issue 4, July 2026.
Abstract MET‐positive gastric cancer (GC) has a poor prognosis. In addition, targeting MET with monoclonal antibodies or tyrosine kinase inhibitors had limited success. We searched for additional genetic alterations that might explain the poor outcome of MET‐positive GC and lack of response to MET‐targeted therapies.
Silke Lüschen, Ulrike Ebert, Hans‐Michael Behrens, Sandra Krüger, Dita Ulase, Anu Amallraja, Steffen M. Heckl, Thomas Becker, Philip Rosenstiel, Tobias Meißner, Christoph Röcken   +10 more
wiley   +1 more source

Advances in Gastric Cancer Research: Insights Into Carcinogenesis, the Tumor Microenvironment, Metastasis, and Factors Influencing Prognosis

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 984-994, July 2026.
ABSTRACT Background The Department of Gastroenterological Surgery at Kumamoto University has maintained a commitment to integrating cutting‐edge clinical practice with fundamental research, particularly concerning malignant diseases of the digestive tract.
Hideo Baba, Takatsugu Ishimoto, Yoshifumi Baba, Hiromitsu Hayashi, Masaaki Iwatsuki   +4 more
wiley   +1 more source

Risks and Benefits of Feeding Enterostomy Creation During Minimally Invasive Esophagectomy: A Propensity‐Weighted Analysis Using the Japanese National Clinical Database

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1042-1050, July 2026.
Feeding enterostomy during MIE was evaluated in 19 054 patients from the Japanese NCD using propensity weighting. Enterostomy was associated with higher reoperation and respiratory complications, but lower delayed gastric emptying and deep vein thrombosis, with no significant difference in overall bowel obstruction.
Eisuke Booka, Shinya Hirakawa, Hisateru Tachimori, Koji Tanaka, Hideki Ueno, Yasue Kimura, Ken Shirabe, Hiroya Takeuchi   +7 more
wiley   +1 more source

Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions Adenocarcinoma da junção esôfago-gástrica: relação entre os dados cllnipatológicos e a imunoexpressão de p53, ciclina D1 e Bcl-2

Arquivos de Gastroenterologia, 2009
CONTEXT: Esophagogastric junction adenocarcinoma has an aggressive behavior, and TNM (UICC) staging is not always accurate enough to categorize patient's outcome.
Dárcio Matenhauer Lehrbach, Ivan Cecconello, Ulysses Ribeiro Jr, Vera Luiza Capelozzi, Alexandre Muxfeldt Ab'Saber, Venâncio Avancini Ferreira Alves   +5 more
doaj   +1 more source

Esophagopericardial fistula as a rare complication after total gastrectomy for cancer

World Journal of Surgical Oncology, 2009
Background Esophagopericardial fistula is a rare but life-threatening complication of benign, malignant or traumatic esophageal disease. It is most commonly associated with benign etiology and carries a high mortality rate which increases with delay in ...
Athanasopoulos Panayiotis, Fragulidis Georgios, Gkiokas Georgios, Polydorou Andreas, Marinis Athanasios, Anastasopoulos Georgios, Dafnios Nikolaos, Theodosopoulos Theodosios   +7 more
doaj   +1 more source

Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery

World Journal of Surgery, Volume 50, Issue 8, Page 2081-2084, August 2026.
Luís Santos Castro, Lorenzo Ferri
wiley   +1 more source